Table 2 Relationship between circPTEN1 and clinical characteristics in CRC patients (n = 150)
Cases | Low expression | High expression | P | ||
|---|---|---|---|---|---|
Gender | Male | 89 | 46 (61%) | 43 (57%) | 0.5652 |
Female | 61 | 29 (39%) | 32 (43%) | ||
Age | ≤60 | 41 | 19 (25%) | 22 (29%) | 0.5241 |
> 60 | 109 | 56 (75%) | 53 (71%) | ||
Tumor size (cm) | ≤5 | 28 | 11 (15%) | 17 (23%) | 0.1493 |
> 5 | 122 | 64 (85%) | 58 (77%) | ||
Differentiation | Well/Moderate | 89 | 42 (56%) | 47 (63%) | 0.3133 |
Poor | 61 | 33 (44%) | 28 (37%) | ||
T stage | T1 + T2 | 64 | 28 (37%) | 36 (48%) | 0.1156 |
T3 + T4 | 86 | 47 (63%) | 39 (52%) | ||
N stage | N0 | 44 | 15 (20%) | 29 (39%) | 0.0032** |
N1 + N2 | 106 | 60 (80%) | 46 (61%) | ||
M stage | M0 | 130 | 61 (81%) | 69 (92%) | 0.0228* |
M1 | 20 | 14 (19%) | 6 (8%) | ||
Pathological stage | I + II | 38 | 12 (16%) | 26 (35%) | 0.0021** |
III + IV | 112 | 63 (84%) | 49 (65%) |